Sunesis Pharmaceuticals (SNSS) Positive Results from Trial of Vosaroxin in AML
Tweet Send to a Friend
Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced the presentation of updated results from an ongoing Phase 1b/2 University of Texas ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
